Will taking ayahuasca help you maximize shareholder value?

Source: Will taking ayahuasca help you maximize shareholder value?, Good Work, 12:57, uploaded 2024-12-20, Watch Later position 630.

Good Work’s Dan Toomey follows ayahuasca from South American healing rituals into the retreat economy that now serves Silicon Valley founders, investors, and other high performers. The video keeps returning to a plain conflict. A ceremony may help someone change the reasons for which they work. Investors may have funded that person to pursue the same company for several more years.

From Amazonian medicine to tech-culture ritual

Ayahuasca is a brown drink made from plants. The opening describes its mud-like appearance and bark taste before cutting to clips of public figures discussing their own experiences, including Joe Rogan. The joke about the project manager who wears wooden beads around the office gives the cultural shift its scale. A practice associated with South American healing rituals has become a recognisable prop in the Western tech world.

Toomey places its rise in American pop culture in the early 2010s, after several celebrities took it, with Chelsea Handler included in the list. The same period brought serious research into psychedelics as possible treatments for depression, anxiety, PTSD, and substance abuse. The video treats that research as part of the reason for the drug’s new reputation, whilst keeping the ceremony itself physical and unpleasant. Kat Courtney, the CEO of Plant Medicine People, describes itching, vomiting, coughing, laughter, and crying. The experience can last for hours, with intense visual effects, memories that seem to unravel, and what she calls the release of trapped energy and emotion through purging.

Courtney also describes the morning after. People may feel peaceful, connected, and free from the usual list of tasks and worries. She calls this her favourite part of the process and says that the feeling often occurs without a guarantee. When people feel adrift and want to change their lives, she says, ayahuasca often becomes the chosen intervention.

The retreat as a premium service

The intensity of the experience has created a global retreat industry. Daniel Yepez of Behold and Brandon Evans of 1Heart describe programmes in Costa Rica that run across seven weeks. Three weeks of online preparation come before a week at the retreat, followed by three weeks of post-ceremony integration. They market the programmes to overachievers and high performers who want to find a greater purpose or apply the experience to work they have already begun.

The setting carries part of the product. The retreats offer waterfalls, horseback riding, fine food, sweat lodges, ice baths, yoga, conscious movement, and comfortable glamping. The experience is meant to feel close to nature whilst retaining the service level of an expensive holiday. Yepez and Evans also say that they offer scholarships and cheaper packages, though the video’s account gives no figures for either claim.

Their language places ayahuasca inside the vocabulary of optimisation. Evans calls it biohacking at the highest level, a way to reach one’s algorithms and core in order to make changes. He compares the sight of someone rolling around, vomiting, and crying to ten years of therapy compressed into a single, turbocharged experience. This is the point at which a spiritual practice becomes legible to a founder culture that already treats sleep, diet, software, and attention as systems to tune.

The costs behind the jungle setting

Ruben Orellana, a Peruvian anthropologist, shifts the focus from the visitor’s transformation to the place that supplies it. A retreat in the jungle still needs electricity, drinking water, toilets, and other infrastructure. Orellana says that the expansion of such centres has damaged the surrounding environment over the last thirty years. He also argues that business owners often sell tourists an imagined life-changing jungle experience whilst paying local workers unfairly.

His criticism concerns the business model and leaves room for retreats that operate well. The visitor pays a high price for a carefully packaged encounter with nature, while the people who provide the local labour and knowledge may receive little of that money. Orellana says that his objections may leave Yepez’s and Evans’s centres outside the scope of his criticism. The video presents his account as a challenge to the industry and keeps its application to individual retreats open.

Toomey’s satire makes the conflict blunt. A founder may spend a week vomiting and searching for salvation whilst the retreat treats the visitor as a source of revenue. The joke lands because the retreat’s premium comforts and its language of cleansing sit beside a claim about underpaid local work and irreversible environmental damage.

What investors think founders should optimise

Marc Andreessen’s objection supplies the financial version of the conflict. The video says that the venture capitalist criticised ayahuasca after speaking about it publicly, because the experience might strip founders of the motivation and drive that investors expect them to bring to their companies. The worry concerns the possibility that founders may discover reasons to stop building the product that attracted the investment.

Bill Kerr, an entrepreneur interviewed after his own experience, describes a difficult ceremony that changed the scale of his concerns. He says that the experience pressed the importance of nature and the environment into his mind until those concerns mattered more to him than something Andreessen had said on Joe Rogan. Life, in Kerr’s account, includes the quality of the time a person has and the things that person enjoys. His investors may have wanted a founder who treated the company as the main object of attention. Kerr comes away with a wider set of obligations.

Eddy Vaisberg, a former founder who now invests in what he calls spirit tech, adds a time horizon to the discussion. A venture capitalist who wants straight-line returns over two or three years may still accept the risk that ayahuasca changes a founder’s priorities. The same experience can expose the reason a person works. A founder who works only for a quick return may question the company once a deeper purpose becomes visible. Vaisberg treats that possibility as a form of alignment. A founder who no longer cares about the work may have learned something relevant about their fitness to remain its founder.

The disagreement therefore concerns the thing being optimised. A fund can measure a short period of returns. A founder has to decide whether the company still deserves years of life. Ayahuasca may help with that decision in the sense that an intense experience can force a change in perspective. The video offers interviews and anecdotes for this claim. It supplies no evidence that the experience improves a company’s performance or produces better investment returns.

Introspection and the founder’s decision

Toomey’s advice keeps the joke tied to the material conditions around the drug. Anyone booking a retreat should check whether the business pays local workers fairly before buying a flight to the jungle. Founders who hope to fall back in love with an app can also discover that the life they are building deserves a different question. The video imagines an Ivy League dating app whose business model amounts to breeding children for investor returns. Ayahuasca might reveal that this work has little to do with the life a founder wants.

A person may reach the same conclusion through honest introspection. The source’s answer to its title is therefore conditional. Ayahuasca can unsettle a founder’s reasons for working, which may help that person or may disappoint an investor. The retreat still has to operate fairly, and the experience does not supply a substitute for examining the work itself.

Limits

Good Work presents this as a satirical reported video. The description names Courtney, Yepez, Evans, Orellana, Kerr, and Vaisberg as interviewees, yet it provides no studies, bibliography, or independent reporting for the video’s claims. Its references to thousands of years of South American use and to current psychedelic research remain broad. The medical possibilities belong to the video’s framing, whilst the claims about therapy, purpose, founder motivation, local wages, and environmental damage come from interviewees or Toomey’s narration.

The downloaded caption track repeatedly misrecognises “ayahuasca” and several names. The spellings in this note follow the video’s description and the surrounding context. The source contains no chapters and gives no basis for measuring whether ayahuasca changes startup outcomes, shareholder value, or the long-term wellbeing of participants.